[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557697":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":24,"responsibleParty":41,"collaborators":43,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":24,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":24,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":82,"overallStatus":85,"whyStopped":24,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":24},{"fullName":5,"class":6},"Zhejiang Provincial People's Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ultra-Fast-Track Cardiac Anesthesia(UFTCA)","EXPERIMENTAL","The researchers implemented an ultra-fast-track anesthesia protocol, and the tracheal tube was removed immediately or within 1 hour of awakening at the end of the operation.",[13],"Procedure: Ultra-Fast-Track Cardiac Anesthesia(UFTCA)",{"label":15,"type":6,"description":16,"interventionNames":17},"conventional general anesthesia (CGA)","The researcher implemented a conventional anesthesia protocol, and participants were not extubated at the end of the procedure and were admitted to the ICU under anesthesia with an endotracheal tube.",[18],"Procedure: conventional general anesthesia (CGA)",[20,25],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","(UFTCA)The researcher removed the endotracheal tube either immediately or within 1 hour of the end of the procedure.",[9],null,{"type":21,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"(CGA)The researcher not extubated at the end of the operation and were admitted to the ICU under anesthesia with an endotracheal tube.",[15],[29],{"name":30,"affiliation":5,"role":31},"Mei J Yan, QC","STUDY_CHAIR",[33,37],{"name":30,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","+863313957116714","1514018695@qq.com",{"name":38,"role":34,"phone":39,"phoneExt":24,"email":40},"Han W Wei, secretary","+863317816112656","wzero1017@163.com",{"type":42,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[44,46,48,50,52,54,56,58,60],{"name":45,"class":6},"Beijing Anzhen Hospital",{"name":47,"class":6},"Fudan University",{"name":49,"class":6},"Wuhan Asia Heart Hospital",{"name":51,"class":6},"Tianjin Chest Hospital",{"name":53,"class":6},"Chinese PLA General Hospital",{"name":55,"class":6},"First Affiliated Hospital Xi'an Jiaotong University",{"name":57,"class":6},"Xiangya Hospital of Central South University",{"name":59,"class":6},"The Fourth Affiliated Hospital of Zhejiang University School of Medicine",{"name":61,"class":6},"Guangdong Provincial People's Hospital","100557697","multicentre-clinical-study-of-ultra-fast-track-anaesthesia-for-minimally-invasive-heart-valve-surgery-100557697",false,"NCT06541483","Multicentre Clinical Study of Ultra-Fast-Track Anaesthesia for Minimally Invasive Heart Valve Surgery","A Multicenter Clinical Study of Ultra-Fast-Track Cardiac Anesthesia in Minimally Invasive Cardiac Surgery for Valvular Heart Disease","Inclusion Criteria:\n\n* Age ≥18 and ≤80 years\n* American Society of Anaesthesiologists (ASA) class I-III\n* New York Heart Association (NYHA) cardiac class III or below\n* Preoperative inspired air pulse oximetry (SpO2) ≥95%\n* Ejection fraction (EF) ≥ 40%\n* No contraindications to nerve blocks\n\nExclusion Criteria:\n\n* Patient's refusal to participate\n* Severe communication disorders\n* Severe disorders of coagulation with spontaneous bleeding tendency\n* Long-term application of opioid analgesics\n* Pulmonary hypertension (mean pulmonary artery pressure ≥55 mmHg)\n* People who need artificial ventilation\n* Allergy to dexmedetomidine and ropivacaine\n* Complex aortic root surgery such as root widening","ALL","18 Years","80 Years",{"count":73,"type":74},1200,"ESTIMATED","INTERVENTIONAL",[77],"NA","The goal of this clinical trial is to evaluate the clinical effects of ultra-fast-track anesthesia (UFTA) for minimally invasive cardiac surgery (MICS) in adults. It will also learn about the safety and feasibility of Ultra-Fast-Track cardiac surgery(UFTCA).The main questions it aims to answer are:Does UFTCA promote rapid postoperative recovery, reduce postoperative complications and perioperative mortality, and improve the quality of mid- and long-term survival.And does it improve patient satisfaction and reduce healthcare costs.\n\nParticipants will receive homogenized perioperative management in the cardiac ward, extracorporeal circulation, and postoperative ICU, except for anesthesia extubation time.Furthermore，Participants need complete quality of life scales at 30 days, 90 days, six months, and one year after surgery, separately.\n\nParticipants in this study are adults who required elective minimally invasive heart valve surgery under extracorporeal circulation.This study will be able to promote rapid recovery while reducing the associated costs and the financial burden on participants.Retrospective big data analysis of perioperative clinical characteristics of patients undergoing minimally invasive heart valve surgery to establish a risk warning model and develop a perioperative management program. The investigators then conducts a randomized group trial comparing the similarities and differences between conventional general anesthesia（CGA） and ultra-fast-track cardiac anesthesia(URTCA) to demonstrate the effectiveness and safety of UFTA in MICS.Finally, building expert consensus.",[80,81],"Heart Valve Diseases","Enhanced Recovery After Surgery",[83,84],"Ultra-fast-track Anesthesia","minimally invasive cardiac surgery","NOT_YET_RECRUITING","2024-08-02",{"date":88,"type":89},"2024-08-07","ACTUAL",{"date":91,"type":74},"2024-12",{"date":93,"type":74},"2028-12",{"name":5,"class":6}]